Alira Health

7e Journée start-up innovantes du dispositif médical

May 10, 2022 | Paris, France

We are thrilled to announce that this year we will be joining 7e Journée start-up innovantes du dispositif médical by SNITEM as Gold Sponsors, exhibitors, speakers, and judges! This event will include multiple workshops and sessions focusing on regulatory, market access, financing, and R&D challenges that MedTech companies face.

Come and find us at stand G6 or connect with our attendees below!

Our workshop: Financement des dispositifs médicaux connectés en France en 2022 : état des lieux et perspectives

Alira Health’s workshop titled “Financement des dispositifs médicaux connectés en France en 2022 : état des lieux et perspectives” will take place from 11:40 AM to 12:40 PM CEST in Room 2 and will cover the following topics (description available in French):

  • Introduction : Quelle(s) définition(s) des DM connectées et les prémices de la prise en charge de la télésurveillance en France : Expérimentations ETAPES
  • Boite à outils pour préparer son financement : quelles questions se poser pour un financement adéquat de sa solution connectée
  • Etat des lieux en France : Publication des référentiels par la HAS autour de la télésurveillance / inscription en nom de marques / autres dispositifs type Article 51, …
  • Quid des autres pays ? Focus synthétique sur la situation dans d’autres pays type EU5
Our speaker
Elodie Lehmann

Elodie Lehmann

Associate Director - Market Access France, Alira Health Expert in pharma and biotech, Elodie focuses on care pathways optimization with a focus on local market access projects. Elodie holds a degree in Biotechnology Engineering from Polytech Marseille, France, and an MSc from Kedge Business School, France.
Our judge
Christophe Michel

Christophe Michel

Associate Director Medical Device and Connected Health, Alira Health Christophe joined SNITEM Jury to designate the 12 most promising start-up companies in the MedTech industry and to define the winner who will receive the SNITEM prize during 7e Journée start-up innovantes du dispositif médical.

Expert in clinical evaluation, clinical risk analysis, and HTA interactions, Christophe holds Master's Degree in Pharmacology, Clinical and Metabolic Pharmacology and Ph.D. in Biomedical Engineering.
Our delegates
Marc Nomaksteinsky

Marc Nomaksteinsky

Partner, Alira Health
Frederic Durand-Salmon

Frédéric Durand-Salmon

VP of Clinical Digital Solutions
Tabatha Bourgois

Tabatha Bourgois

Business Development Manager, Regulatory, Alira Health
Pierre Muguet

Pierre Muguet

Global Business Development Manager MedTech, Alira Health
Jonathann Rouimi

Jonathann Rouimi

Strategy Consultant, Alira Health
Marie Vaillant

Marie Vaillant

Associate Consultant, Alira Health
Sarah Sadeuk

Sarah Sadeuk

Junior Consultant, Alira Health
Margaux Casteur

Margaux Casteur

Healthcare Strategy Associate Consultant, Alira Health
Antoine Ewald

Antoine Ewald

Healthcare Strategy Consultant, Alira Health
Matteo Beretta

Matteo Beretta

Strategy and Transaction Consultant - Life Sciences, Alira Health
Marine Meyer

Marine Meyer

Consultant, Alira Health
Erwan Autin

Erwan Autin

Senior Consultant Market Access, Alira Health
Ons Ben Dhia

Ons Ben Dhia

Consultant, Alira Health

Related news

News September 1, 2026
Alira Health Advises Mindful Capital Partners on the Sale of Portfolio Company Sidam S.r.l. to Plastiflex Group
Alira Health is pleased to have acted as Vendor Due Diligence Advisor to Mindful Capital Partners, an independent cross-border private equity firm focused on mid-market companies across(...)
MedTech
Reports and White Papers September 1, 2026
Global Medtech Contract Development and Manufacturing Market H1 2026 M&A Update
Learn about the H1 2026 M&A trends in the medtech CDMO market including deal activity, geographic distribution of transactions, and target end-markets.
CDMO MedTech
Articles August 19, 2026
How to Develop Global Clinical Evidence Strategies for Regulatory Success in Medtech
Discover how a strategically planned clinical evidence generation strategy can support global device approval, maximize evidence value, and prepare for international expansion.
MedTech Regulatory
Events July 24, 2026
MedTech World Asia 2026
Meet our team at MedTech World Asia 2026 and learn how our integrated model can support your international expansion and drive commercial success.
MedTech
Articles July 24, 2026
How Pharma and Medtech Convergence Is Changing DDS Partner Selection in 2026
Learn how pharma and medtech convergence is reshaping drug delivery system partner selection, from combination products and regulatory readiness to integrated execution.
Drug Delivery MedTech Pharma
Articles May 12, 2026
Frequently Asked Questions on the Strategic Value of Dual Branding in Pharma
Discover how dual branding in pharma enables pricing flexibility and expands access, and how to design a strategy that protects value and withstands scrutiny.
Interview Market Access Pharma
Articles April 24, 2026
From Approval to Adoption: A New Framework for Medtech Success
Medtech success requires more than approval. Discover how aligning evidence, patient needs, and market access drives adoption.
Interview MedTech Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.